The role of glioma microenvironment in immune modulation: Potential targets for intervention

Mahua Dey, S. Farzana Hussain, Amy B. Heimberger*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

12 Scopus citations

Abstract

Malignant gliomas are associated with poor prognoses despite surgical, radiation and chemotherapy interventions. Since notable side-effects are associated with each of the aforementioned therapies, the future design of glioma immunotherapy clinical trials will need to address immune modulation at multiple levels for efficacious results. The review discusses emerging data that provides novel insights into immune modulation and their possible implications for immunotherapeutic approaches. The next generation of immunotherapy is largely focused on improving immune effector targeting and directing the tumor immune microenvironment to work synergistically with systematic immune activation.

Original languageEnglish (US)
Pages (from-to)443-453
Number of pages11
JournalLetters in Drug Design and Discovery
Volume3
Issue number7
DOIs
StatePublished - 2006
Externally publishedYes

Keywords

  • Antigen presenting cells
  • Central nervous system
  • Dendritic cell
  • Glioblastoma multiforme
  • Microglia
  • Regulatory T cell

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmaceutical Science
  • Drug Discovery

Fingerprint

Dive into the research topics of 'The role of glioma microenvironment in immune modulation: Potential targets for intervention'. Together they form a unique fingerprint.

Cite this